Home > Mutants (Isolated)

Mutants (Isolated)

NBRP C. elegans is charging the handling and shipping fee to the recipients of strains. This action is regulated by the Japanese government. The fee is 1,800 Japanese Yen per strain (11,000 JPY for profit companies). Please pay the amount when you receive the Invoice attached with an e-mail. Thank you for your understanding and cooperation.

Please visit our payment system Website as informed in the Invoice enclosed with the strains. You can pay the amount of money by credit cards for each shipping. If you have problem to access our payment system website, please send an e-mail to the Core Facility (Mitani Laboratory) so that we can send back the website URL link.
Last Update 2019-11-11
Allele NameSequence NameCGC NamePhenotypeBalancerRequest
tm232 C30A5.7 unc-86 homozygous viable
tm233 ZK154.4 ZK154.4 homozygous viable
tm234 C54C6.2 ben-1 homozygous viable. Dr. Z. Zhou: no persistent cell corpses.
tm235 ZK783.4 flt-1 homozygous viable. Dr. R. Horvitz: does not suppress synMuv phenotype.
tm236 C24A8.3 pqn-15 homozygous viable
tm237 C17H12.9 ceh-48 homozygous viable. Dr. D. Portman: male tail appears grossly normal.
tm238 C36F7.1 irx-1 homozygous viable; Dr. H. Sawa: 0% Psa (n=98); Dr. J-L. Bessereau: deletion is within an intron and does not affect gene expression. Dr. D. Portman: male tail appears grossly normal. Dr. D.M. Miller: no gross phenotype is found unlike tm3354.
tm239 C33D12.1 ceh-31 homozygous viable. Dr. J.K. Liu: no defects in the M lineage. Dr. R. Waterston: Dead eggs <10%.
tm240 F42G2.6 F42G2.6 homozygous viable
tm241 C18B12.3 dsc-1 homozygous viable. Dr. S. Hekimi: Development in press.
tm242 T13C5.4 ceh-54 homozygous viable. Egl?
tm243 B0464.5a spk-1 Sterile, balanced with eT1 eT1
tm244 C10G8.7 ceh-33 homozygous viable. Dr. K.L. Chow: No observable defect in males, all animals have wild-type movement and morphology.Dr. R. Waterston: Dead eggs=0/200.
tm245 W05E10.3 ceh-32 lethal or sterile. Dr. A. Chisholm, Dr. E. Lundquist: L1 lethal. eT1
tm246 C44C1.4a vps-45 maternal effect larval lethal. Dr. G. Hermann: WT gut granules.Dr. S. L'Hernault: could not recover.Dr. S. Mitani: EMBOR 8, 152 (2007). dpy-3 (e27) X
tm248 F45C12.15 F45C12.15 homozygous viable
tm249 ZC64.4 lim-4 homozygous viable
tm250 D1007.1 ceh-17 homozygous viable
tm251 C37E2.4 ceh-36 Lethal or sterile. Dr. O. Hobert: no defect in ASE development. Dr. T. Buerglin: complicated rearrangement. Not Yet Balanced
tm252 C39E6.4 mls-2 homozygous viable. Dr. J. Liu: Development 132, 4119-4130 (2005). Dr. P. Sengupta: devective development of chemosensory neurons.
tm253 C37E2.5 ceh-37 lethal or sterile. Dr. J. Karlseder: normal telomere length regulation. unc-3 (e151) X
tm254 C37E2.5 ceh-37 homozygous viable. Dr. J. Karlseder: normal telomere length regulation.
tm256 F22A3.5 ceh-60 homozygous viable
tm257 C25B8.1 kqt-1 homozygous viable
tm258 K12H4.1 ceh-26 lethal or sterile. Dr. M. Barr: male mating behavior normal, pkd-2::gfp expression normal. hT2
tm259 ZK1193.5 dve-1 lethal or sterile?. Dr. P. Sengputa: normal dye filling. Dr. W.B. Derry: non-Mendelian inheritance. Deletion is unstable extrachromosomal? Dr. C. Yang: normal cell death phenotype.
tm260 R07B1.1 vab-15 lethal or sterile. Dr. O. Hobert: affects deveopment of postdeirid neurons. Not Yet Balanced
tm261 T26C11.6 ceh-21 homozygous viable. Dr. J. Kaplan: non-Egl, non-Unc.
tm262 F22A3.5 ceh-60 lethal or sterile.
tm263 C30A5.7 unc-86 homozygous viable
tm264 R04A9.5a R04A9.5a homozygous viable
tm265 T26C11.7 ceh-39 homozygous viable. Dr. D. Portman: male tail is morphologically wile-type.
tm266 T26C11.6 ceh-21 homozygous viable
tm267 C33D12.7 ceh-30 homozygous viable
tm268 C40H5.5 ttx-3 homozygous viable. Dr. Y. Ohshima (J. Exp. Biol. 206, 2581- 2593, 2003)
tm269 W03A5.1 W03A5.1 homozygous viable
tm270 C27A12.5 ceh-2 homozygous viable
tm271 C34C6.8 ceh-7 homozygous viable
tm272 C33D12.7 ceh-30 homozygous viable. Dr. P. Sengupta: normal development of AWA neurons.
tm273 C49C3.5 C49C3.5 lethal or sterile Not Yet Balanced
tm275 C17C3.10 hlh-27 lethal or sterile. Dr. R. Lin: normal cell division during 8-30 cell stage. Dr. P. Sengupta normal dye-filling into sensory neurons (heterozygote). Dr. J. Priess: Dev. Cell 8, 867-879 (2005). Dr. M. Maduro: normal early development (8-30 cell stage). Not Yet Balanced
tm276 C18A3.8 hlh-14 homozygous viable. Dr. G. Garriga: missing PHB neurons.
tm277 F38C2.2 hlh-17 homozygous viable. Dr. S. Shaham: no defects in CEP sheath cells or associated neurons. Dr. C.M. Johnson: normal egg-laying and chemoatraction to lysine and Na ion.
tm278 F40H6.4 tbx-11 homozygous viable. Dr. R. Lin: Dev. Biol. 276, 493-507 (2004).
tm279 F38C2.2 hlh-17 homozygous viable. Dr. S. Shaham: no defects in CEP sheath cells or associated neurons. Dr. C.M. Johnson: normal egg-laying and chemoatraction to lysine and Na ion.
tm280 C44C10.8 hnd-1 homozygous viable. Dr. L. Mathies: ~30% embryonic and early larval lethal with body morphogenesis defects, ~50% of surviving adults have gonadogenesis defects. Phenotype is similar to q740. Dr. O. Hobert: ASE & AIY fate markers normal.
tm281 ZK682.4 hlh-10 homozygous viable
tm282 F21H11.3 tbx-2 lethal or sterile. Dr. P. Okkema: L1 arrest with pharyngeal defects, recessive. eT1,dpy-17 (e164) III
tm284 F31A3.4 hlh-29 homozygous viable. Dr. R. Lin, Dr. M. Maduro: normal cell division during 8-30 cell stage. Dr. P. Sengupta: normal dye-filling into sensory neurons. Dr. J. Priess: Dev. Cell 8, 867-879 (2005). Dr. O. Hobert: ASE & AIY fate markers normal. Dr. C.M. Johnson: BBA 1769, 5 (2007).
tm287 C17C3.8 hlh-26 homozygous viable. Dr. P. Sengupta: normal dye-filling into sensory neurons.
Allele Name
Sequence Name
CGC Name
Worm BaseAllele Name
CGC Name
Sequence
Phenotype
Mutation site
Chromosome
Putative gene structure
Map position
Balancer
Map position of balancer
Sequence of primers
Distributed lab
Depositor
References Please submit your publication
  • papers are available.